Series A Biopharma Companies

Warp Sciences is a life sciences infrastructure company that integrates artificial intelligence and advanced robotics.

HydRegen is a biotechnology company that provides sustainable solutions for chemical manufacturing.

CAD Therapeutics is a biopharmaceutical company developing novel therapeutic candidates targeting post-traumatic stress disorder.

Breye Therapeutics, a biopharmaceutical firm that provide cutting-edge oral treatments for the management of retinal vascular diseases.

Matisse Pharmaceuticals is a biopharmaceutical company developing therapies for sepsis and septic shock by targeting cytotoxic histones.

RegCell develops cell therapies designed to restore immune tolerance in autoimmune diseases.

Solstice Oncology develops immuno-oncology therapies focused on treating and preventing cancer through targeted approaches.

SiccaNova Therapeuticsis a startup developing novel low-molecular therapeutics targeting dry mouth (xerostomia) and dry eye conditions.

Typewriter Therapeutics develops mRNA-based gene therapies using a gene writing platform for site-specific insertion of therapeutic genes.

Tikva Allocell is a biotechnology company that specializes in next-gen cell therapies.

Anodyne Nanotech is a preclinical-stage biotech company that develops differentiated, transdermal forms of high-value drugs.

Rapalogix Health is a biotechnology company focused on developing longevity-based solutions for skin health and dermatological conditions.

MultiValent Biotherapies is a biotechnology company.

Mammogen specializes in improving the detection, diagnosis, and treatment of breast cancer, from end-to-never-end.

Countable Labs provides a PCR system for single-molecule counting and high-sensitivity molecular detection in biotechnology.

Ember LifeSciences is a healthcare technology company that develops cold chain solutions for transporting temperature-sensitive medicines.

cAMPfield Therapeutics is a biotechnology company that specializes on exploration and development activities of therapeutic solutions.

Latus Bio develops gene therapy candidates, particularly for treating central nervous system (CNS) disorders using screened AAV capsids.

CoultreonBiopharma is developing best-in-class therapeutics that target clinically validated pathways in immunology and metabolic illnesses.

Fathom Therapeutics focuses on drug design by harnessing biomolecular motion to develop therapeutics that can reprogram protein function.

Stipple Bio is a biotechnology company that offers cellular profiling and target discovery with epitope resolution.

VST Bio is a biotechnology company that offers and develops treatment for vascular diseases.

This company is a California-based biotechnology firm developing novel small molecule lipids, referred to as oxysterols.

Prenosis develops data-driven diagnostic tools and precision medicine solutions for acute care conditions.

Pranax is a biotechnology company that develops and commercializes regenerative medicine solutions centered on exosome technology.